passage bio stock price
If you are looking for stocks with good return Passage Bio Inc stock can be a bad high-risk. Current Stock Price for Passage Bio PASG.
Sustainability Free Full Text Sustainability In The Canadian Egg Industry Learning From The Past Navigating The Present Planning For The Future Html
View Passage Bio Inc.
. That Passage BIOs share price could reach 2667 by Jan 19 2023. According to the issued ratings of 4 analysts in the last year the consensus rating for Passage Bio stock is Buy based on the current 1 hold rating and 3 buy ratings for PASG. The potential of gene therapy is unlimited but potential doesnt save livesmedicines do.
A groundbreaking research and development model. 102 rows Passage Bio Inc. Learn more about our company.
PASG a clinical-stage genetic medicines company focused on developing transformative therapies for rare monogenic central nervous system disorders today announced that Bruce. PASG is 47 last updated Fri Feb 04 2022 210002 GMT0000 Coordinated Universal Time. If you had invested in Passage BIO stock at 2220 your return over the last 1 years would have been -7838 for an annualized return of -7838 not including any dividends or.
Δ 5 Yr. Fulfilling the promise of gene therapy. View the latest PASG stock quote and chart on MSN Money.
5 rows Compare PASG Stock to Peers. 85 rows Intraday High. As of 138pm ET.
About the Passage Bio Inc. PASG NasdaqGS - NasdaqGS Real Time Price. The average Passage BIO stock price prediction forecasts a potential upside of 44984 from the current PASG share price of 485.
Get the latest Passage Bio stock price and detailed information including PASG news historical charts and realtime prices. As of 2022 January 10 Monday current price of PASG stock is 5620 and our data indicates that the asset price has been in a downtrend for the past 1 year or since its inception. Stock was originally listed at a price of 2220 in Feb 28 2020.
A The stock price for Passage Bio NASDAQ. Their forecasts range from 600 to 4500. On average Wall Street analysts predict.
4 Wall Street analysts have issued twelve-month target prices for Passage Bios shares. Stock analysis for Passage Bio Inc PASGNASDAQ GS including stock price stock chart company news key statistics fundamentals and company profile. So far 200531 shares have traded compared to average volume of 301411 shares.
The average twelve-month price target for Passage Bio is 2400 with a high price target of 4500 and a low price target of 600. Our focus is on producing medicines that will transform the lives of patients and their families. Passage Bio Inc PASG stock is trading at 422 as of 318 PM on Tuesday Feb 15 a gain of 016 or 394 from the previous closing price of 406.
Δ 1 Yr. This suggests a possible upside of 5522 from the stocks current price. Learn more on PASGs analyst rating history.
Get the latest Passage Bio Inc. Dive deeper with interactive charts and top stories of PASSAGE BIO INC. Passage Bio stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period.
PASG investment stock information. Common Stock PASG Stock Quotes - Nasdaq offers stock quotes market activity data for US and global markets. The Closing Price.
1000 -403 Passage Bio to Report Second Quarter 2021 Financial Results on August 5 2021 GlobeNewswire - Thu Jul 29 615AM CDT. Volume today is low. According to 7 analysts the average rating for Passage Bio stock is Strong Buy The 12-month stock price forecast is 2625 which is an increase of 54024 from the latest price.
On average they anticipate Passage Bios stock price to reach 2400 in the next year. Open Price Low Price High Price Close Price Prev Close. Today 52-Week Range.
PASG detailed stock quotes stock data Real-Time ECN charts stats and more. BATS BZX Real-Time Price. The stock has traded between 413 and 430 so far today.
Passage Bio Site Design Website Design Inspiration Web Design
Bykjy6gv93pzpm
Genetically Modified Crops Transgenics And Cisgenics Attra Sustainable Agriculture Project
Passage Bio Announces Inducement Awards Under Nasdaq
Exclusive Interview The Motley Fool Sits Down With Bruce Linton The Motley Fool
Passage Bio Inc Financials Pasg Barron S
Bykjy6gv93pzpm
Passage Bio Stock Forecast Down To 0 000001 Usd Pasg Stock Price Prediction Long Term Short Term Share Revenue Prognosis With Smart Technical Analysis
Should Biotechnology Stock Intercept Pharmaceuticals Inc Icpt Be In Your Portfolio Friday